MTOR and glioblastoma: A similar dual PI3K/mTOR inhibitor (GNE-317) has also been identified and optimized to cross the BBB [32], that study mainly characterized the brain penetration, pathway modulation in the brain, and efficacy of GNE-317 in orthotopic xenograft models of GBM.